KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Short term Debt (2016 - 2026)

Bristol Myers Squibb has reported Short term Debt over the past 18 years, most recently at $2.3 billion for Q1 2026.

  • Quarterly Short term Debt fell 35.06% to $2.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.3 billion through Mar 2026, down 35.06% year-over-year, with the annual reading at $2.3 billion for FY2025, 10.51% up from the prior year.
  • Short term Debt was $2.3 billion for Q1 2026 at Bristol Myers Squibb, up from $2.3 billion in the prior quarter.
  • Over five years, Short term Debt peaked at $7.5 billion in Q1 2022 and troughed at $1.1 billion in Q3 2024.
  • The 5-year median for Short term Debt is $3.5 billion (2024), against an average of $3.7 billion.
  • Year-over-year, Short term Debt surged 323.3% in 2022 and then tumbled 80.28% in 2024.
  • A 5-year view of Short term Debt shows it stood at $4.3 billion in 2022, then decreased by 26.85% to $3.1 billion in 2023, then plummeted by 34.4% to $2.0 billion in 2024, then grew by 10.51% to $2.3 billion in 2025, then rose by 2.08% to $2.3 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Short term Debt are $2.3 billion (Q1 2026), $2.3 billion (Q4 2025), and $4.5 billion (Q3 2025).